The core activity of IntiQuan AG is the provision of services in the field of pharmacometrics and strategic consulting for the pharmaceutical industry. The company offers Model-informed Drug Development (MIDD) solutions that enable the support of drug development through the application of modeling and simulation methods. The services include, among other things, the performance of pharmacokinetic and pharmacodynamic modeling, the analysis of clinical data, and the development of strategies for the market launch of drugs.